What is the appropriate evaluation and management of hypernatremia in a patient with traumatic brain injury?

Evaluation of Hypernatremia in Traumatic Brain Injury

In TBI patients with hypernatremia, immediately measure serum sodium, serum osmolality, urine osmolality, and urine output to differentiate between central diabetes insipidus (the most critical cause), iatrogenic hypernatremia from hypertonic saline therapy, and adipsic hypernatremia—as hypernatremia is an independent predictor of mortality in TBI. 1, 2

Diagnostic Algorithm

Initial Laboratory Assessment

When hypernatremia is detected in a TBI patient, obtain the following within 6 hours 3:

• Serum sodium concentration (critical threshold: >155 mmol/L requires intervention hold)
• Serum osmolality (target monitoring: 330-431 mosm/L range documented in protocols)
• Urine osmolality and specific gravity
• Urine output (polyuria >3 mL/kg/hr suggests diabetes insipidus)
• Serum creatinine (to assess renal function)
• Blood glucose (to exclude hyperosmolar hyperglycemic state)

Differentiate the Etiology

Central Diabetes Insipidus (AVP-D) is the most ominous cause and represents a poor prognostic indicator, often heralding rising intracranial pressure and death 1, 2. Look for:

• Hypotonic polyuria (urine osmolality <300 mosm/kg)
• Onset typically within first days post-injury
• High mortality when presenting very early after trauma 2
• May be transient (days to weeks) or permanent

Iatrogenic Hypernatremia from hypertonic saline therapy 3:

• Review recent 3% saline administration
• Serum sodium should be measured within 6 hours of bolus dosing
• Re-administration should not occur until sodium <155 mmol/L 3
• Sustained hypernatremia up to 170-187 mEq/L has been tolerated in protocols 4

Adipsic Hypernatremia (rare but critical) 5:

• Severe hypernatremia with absent thirst sensation
• Preserved urinary concentrating ability (distinguishes from DI)
• Hypothalamic dysfunction from TBI
• Consider even with unremarkable neuroimaging 5

Critical Monitoring Parameters

Frequency of Assessment

• Serum sodium: Every 6 hours during acute phase 3
• Fluid balance: Continuous monitoring of intake/output
• Intracranial pressure and cerebral perfusion pressure: Continuous if monitored 4
• Renal function: Daily creatinine (risk of acute kidney injury with severe hyperosmolality) 4, 5

Red Flags Requiring Immediate Action

• Serum sodium >155 mmol/L: Hold hypertonic saline if being administered 3
• Polyuria with dilute urine: Suggests diabetes insipidus—initiate desmopressin trial
• Absent thirst with severe hypernatremia: Consider adipsic hypernatremia—requires scheduled oral/enteral hydration 5
• Rising ICP with hypernatremia: May indicate brainstem compression and impending herniation 2

Additional Considerations

Thromboembolic Risk: Severe hyperosmolality from combined hypernatremia and hyperglycemia dramatically increases risk of extensive DVT and pulmonary embolism 5. Maintain high index of suspicion and consider prophylactic anticoagulation when safe.

Chloride Monitoring: While hypernatremia receives primary focus, concurrent hyperchloremia is independently associated with increased mortality in TBI 6. Monitor chloride levels, particularly with high-volume saline administration.

Renal Function: Sustained hyperosmolarity (>364 mosm/L) can precipitate acute renal failure, though this is typically reversible with appropriate management 4. Two of ten patients in one series required continuous veno-venous hemodialysis, both recovering full renal function.

Common Pitfalls to Avoid

• Assuming all hypernatremia is therapeutic: Always verify if hypertonic saline is being administered and at what dose
• Missing diabetes insipidus: Early-onset DI has particularly high mortality and requires immediate recognition 2
• Ignoring thirst assessment: Absence of thirst despite severe hypernatremia is pathognomonic for adipsic hypernatremia 5
• Overcorrecting too rapidly: While recent evidence challenges historical correction rates, maintain controlled correction to avoid complications
• Neglecting volume status: Severe dehydration compounds neurological injury—many TBI patients cannot compensate with adequate fluid intake 2

The evidence strongly indicates that hypernatremia in TBI is not merely an electrolyte abnormality but a marker of injury severity and predictor of mortality 1. The distinction between therapeutic hypernatremia (intentional for ICP control), pathological hypernatremia (diabetes insipidus, adipsic), and iatrogenic hypernatremia (excessive therapy) is critical for appropriate management and prognostication.